amifostine anhydrous has been researched along with Dysgeusia in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Dysgeusia: A condition characterized by alterations of the sense of taste which may range from mild to severe, including gross distortions of taste quality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A wide range in reported prevalence of dysgeusia was identified with the weighted prevalence from 56-76%, depending on the type of cancer treatment." | 2.46 | A systematic review of dysgeusia induced by cancer therapies. ( Brennan, MT; Elting, LS; Hovan, AJ; Ohrn, KE; Spijkervet, FK; Stevenson-Moore, P; Wahlin, YB; Williams, PM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hovan, AJ | 1 |
| Williams, PM | 1 |
| Stevenson-Moore, P | 1 |
| Wahlin, YB | 1 |
| Ohrn, KE | 1 |
| Elting, LS | 1 |
| Spijkervet, FK | 1 |
| Brennan, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment: a Prospective Cohort Study on Patients Affected by Breast Cancer[NCT03210441] | 204 participants (Anticipated) | Observational | 2014-05-06 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for amifostine anhydrous and Dysgeusia
| Article | Year |
|---|---|
A systematic review of dysgeusia induced by cancer therapies.
Topics: Amifostine; Dysgeusia; Humans; Neoplasms; Prevalence; Quality of Life; Zinc Sulfate | 2010 |
1 other study available for amifostine anhydrous and Dysgeusia
| Article | Year |
|---|---|
Chemoradiotherapy for head and neck cancer: 'local' side effects are actually systemic.
Topics: Amifostine; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Deglutition Di | 2006 |